Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

The debate over Florida’s HIV medication cuts is intensifying as advocates, lawmakers, and healthcare professionals push back ...

Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Advocates and patients warn thousands of Floridians living with HIV could lose access to life-saving medications under ...

Until last year, the number of children orphaned because a parent died from AIDS, was plummeting. That's thanks to America's 20 year effort to get lifesaving HIV meds to millions in need. But last ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

HOUSTON — With President Trump's "Big, Beautiful Bil l," making major cuts to Medicaid, health care professionals and patients are warning of the potentially deadly consequences for people living with ...

An estimated 10,000 people are about to lose access to their HIV medication as the Florida Department of Health makes cuts to ...